[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Tuesday, 15 July, 2003, 14:51 GMT 15:51 UK
Dolly firm to cull its sheep
Flock of sheep
The firm currently has a flock of 3,000 genetically modified sheep
The company which created Dolly the sheep clone is to cull hundreds of animals after trials of a new treatment for lung disorders were shelved.

PPL Therapeutics has been in difficulty since its transgenic (genetically modified) sheep programme was put on hold by the firm's German backers.

The company, based at Roslin, near Edinburgh, said it could no longer afford to look after the 3,000-strong flock but it would keep some of the original sheep for future breeding programmes.

In June, the company announced that it would have to lay off between 90 and 140 staff after the project to commercialise recombinant Alpha-1 Antitrypsin (AAT) - a medicine to help lung disorders made from the milk of genetically modified sheep - was halted.

A spokesman confirmed that the firm would be scaling down its operation, but was still assessing how many sheep on its 500-acre site in East Lothian would need to be slaughtered.

In New Zealand, where PPL Therapeutics has a 3,500-strong flock, the company is reportedly planning to slaughter up to 1,000 of the animals.

Dolly death

However the spokesman added that the company would keep some of the original founding sheep for future breeding programmes.

He said: "Unfortunately, placing the AAT programme on hold has also meant that PPL can no longer support all its AAT sheep flock and work is under way to reduce sheep numbers on its farms in both Scotland and New Zealand.

"PPL is evaluating the option of keeping a significant number of its transgenic sheep to maintain the viability of its transgenic technology business.

"The sheep will be euthanased with full concern for animal welfare and in line with the necessary Government regulations."

Dolly the sheep
The firm was behind the creation of Dolly the sheep
The company developed the world's first transgenic sheep, Tracy, in 1991, before hitting the headlines in 1996 with the creation of Dolly.

In the same year it opened a production facility which included a computer-controlled milking parlour and technology to monitor each sheep electronically.

Dolly - named after country and western singer Dolly Parton because she was cloned from a breast cell - died on St Valentine's Day at the age of six after developing a lung tumour and arthritis.

The company announced major restructuring in the wake of last month's announcement by Bayer. The changes could see up to 90% of the PPL workforce lose their jobs.


SEE ALSO:
Dolly firm drops plant plan
28 Apr 03  |  Scotland
Losses increase at biotech firm
25 Mar 02  |  Business
Doubts over 'pharming' technology
25 Mar 02  |  Science/Nature
Dolly's arthritis sparks cloning row
04 Jan 02  |  Science/Nature
How Dolly became a cash cow
10 Sep 98  |  Science/Nature


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific